About
Technology
Issues
FAQ
Links
Official Page
First-in-Human Evaluation of the Safety and Immunogenicity of an Intranasally Administered Replication-Competent Sendai Virus–Vectored HIV Type 1 Gag Vaccine: Induction of Potent T-Cell or Antibody Responses in Prime-Boost Regimens
Distribution of the number of citations over years.
site/software ©
exaly
; All materials licenced under
CC by-SA
.